FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.


FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.


A digital reconstruction of the brain's power source

The EPFL Blue Brain Project has created the first digital reconstruction of the Neuro-Glia-Vascular Architecture providing a new framework to study brain function in health and disease. The study, published in Cerebral Cortex, ...

Arthritis & Rheumatism

An experimental vaccine against rheumatoid arthritis

Researchers at The University of Toledo have developed an experimental vaccine that shows significant promise in preventing rheumatoid arthritis, a painful autoimmune disease that cannot currently be cured.


New drug shows real promise against celiac disease

An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found—raising hopes that it could become the first medication for the serious digestive disorder.

page 1 from 30

Experimental drug

An experimental drug is a substance that has been tested in a laboratory and has got approval from regulatory authorities to be tested in people. In the United States, the body responsible for approval is the U.S. Food and Drug Administration (FDA). A drug may be approved for use in one disease or condition but be considered experimental or investigational in other diseases or conditions.

This text uses material from Wikipedia, licensed under CC BY-SA